APA

Douglas A. D., Williams A. R., Illingworth J. J., Kamuyu G., Biswas S., Goodman A. L., Wyllie D. H., Crosnier C., Miura K., Wright G. J., Long C. A., Osier F. H., Marsh K., Turner A. V., Hill A. V. S. & Draper S. J. (20120402). The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. : Nature communications.

Chicago

Douglas Alexander D, Williams Andrew R, Illingworth Joseph J, Kamuyu Gathoni, Biswas Sumi, Goodman Anna L, Wyllie David H, Crosnier Cécile, Miura Kazutoyo, Wright Gavin J, Long Carole A, Osier Faith H, Marsh Kevin, Turner Alison V, Hill Adrian V S and Draper Simon J. 20120402. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. : Nature communications.

Harvard

Douglas A. D., Williams A. R., Illingworth J. J., Kamuyu G., Biswas S., Goodman A. L., Wyllie D. H., Crosnier C., Miura K., Wright G. J., Long C. A., Osier F. H., Marsh K., Turner A. V., Hill A. V. S. and Draper S. J. (20120402). The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. : Nature communications.

MLA

Douglas Alexander D, Williams Andrew R, Illingworth Joseph J, Kamuyu Gathoni, Biswas Sumi, Goodman Anna L, Wyllie David H, Crosnier Cécile, Miura Kazutoyo, Wright Gavin J, Long Carole A, Osier Faith H, Marsh Kevin, Turner Alison V, Hill Adrian V S and Draper Simon J. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. : Nature communications. 20120402.